Chandan Basho - 16 May 2023 Form 4/A - Amendment Insider Report for Apollo Medical Holdings, Inc. (ASTH)

Role: Chief Financial Officer and Chief Strategy Officer
Signature: /s/ Chandan Basho
Issuer symbol: ASTH
Transactions as of: 16 May 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 17 Oct 2023, 16:16:30 UTC
Date Of Original Report: 25 May 2023
Previous filing: 17 Oct 2023
Next filing: 22 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMEH	Common Stock	Disposed to Issuer	$0	-48,086	-65%	$0.000000	26,359	16 May 2023	Direct	F1
transaction	AMEH	Common Stock	Award	$0	+9,121	+35%	$0.000000	35,480	16 May 2023	Direct	F2, F5
transaction	AMEH	Common Stock	Award	$0	+60,808	+171%	$0.000000	96,288	16 May 2023	Direct	F3, F5
transaction	AMEH	Common Stock	Award	$0	+60,803	+63%	$0.000000	157,091	16 May 2023	Direct	F4, F5, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents cancellation of previously-granted performance-based restricted stock award. The original Form 4 filed on May 25, 2023 inadvertently omitted this cancellation. Total holdings in column 5 have been adjusted accordingly, including for previously-reported tax withholdings.
F2	Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in two equal (as nearly as possible) annual installments beginning on May 16, 2024.
F3	Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest in four equal (as nearly as possible) annual installments, beginning on May 16, 2024.
F4	Represents restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares shall vest upon achievement of certain pre-established performance goals.
F5	These grants were previously reported in the aggregate in the original Form 4 filed on May 25, 2023.
F6	Includes 152,372 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 21,640 shares, which vest in three equal annual installments on April 14, 2024, 2025, and 2026; (ii) 9,121 shares, which vest in two equal annual installments on May 16, 2024 and 2025; (iii) 60,808 shares, which vest in four equal annual installments on May 16, 2024, 2025, 2026 and 2027; and (iv) 60,803 shares, which vest upon achievement of certain pre-established performance goals.

Remarks:

Chief Financial Officer and Chief Strategy Officer